table of content
1 Introduction to Research & Analysis Reports
1.1 Human Microbiome Based Drugs and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Microbiome Based Drugs and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Microbiome Based Drugs and Diagnostics Overall Market Size
2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size: 2022 VS 2029
2.2 Global Human Microbiome Based Drugs and Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Microbiome Based Drugs and Diagnostics Players in Global Market
3.2 Top Global Human Microbiome Based Drugs and Diagnostics Companies Ranked by Revenue
3.3 Global Human Microbiome Based Drugs and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Based Drugs and Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Microbiome Based Drugs and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Human Microbiome Based Drugs and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Based Drugs and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Microbiome Based Drugs and Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Therapeutics
4.1.3 Diagnostics
4.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2022 & 2029
5.1.2 Clinical Research Institutes
5.1.3 Hospital
5.1.4 Surgical Centers
5.1.5 Others
5.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.3.2 US Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.3.3 Canada Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.3.4 Mexico Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.4.2 Germany Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.3 France Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.4 U.K. Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.5 Italy Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.6 Russia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.4.8 Benelux Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.5.2 China Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.3 Japan Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.4 South Korea Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.5.6 India Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.6.2 Brazil Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.6.3 Argentina Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Microbiome Based Drugs and Diagnostics Revenue, 2018-2029
6.7.2 Turkey Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.3 Israel Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
6.7.5 UAE Human Microbiome Based Drugs and Diagnostics Market Size, 2018-2029
7 Human Microbiome Based Drugs and Diagnostics Companies Profiles
7.1 Second Genome
7.1.1 Second Genome Company Summary
7.1.2 Second Genome Business Overview
7.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.1.4 Second Genome Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Second Genome Key News & Latest Developments
7.2 Enterome Bioscience
7.2.1 Enterome Bioscience Company Summary
7.2.2 Enterome Bioscience Business Overview
7.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.2.4 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Enterome Bioscience Key News & Latest Developments
7.3 Yakult
7.3.1 Yakult Company Summary
7.3.2 Yakult Business Overview
7.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.3.4 Yakult Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Yakult Key News & Latest Developments
7.4 Dowdupont
7.4.1 Dowdupont Company Summary
7.4.2 Dowdupont Business Overview
7.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.4.4 Dowdupont Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Dowdupont Key News & Latest Developments
7.5 Vedanta BioSciences
7.5.1 Vedanta BioSciences Company Summary
7.5.2 Vedanta BioSciences Business Overview
7.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.5.4 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Vedanta BioSciences Key News & Latest Developments
7.6 Metabiomics Corporation
7.6.1 Metabiomics Corporation Company Summary
7.6.2 Metabiomics Corporation Business Overview
7.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.6.4 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Metabiomics Corporation Key News & Latest Developments
7.7 ViThera Pharmaceuticals
7.7.1 ViThera Pharmaceuticals Company Summary
7.7.2 ViThera Pharmaceuticals Business Overview
7.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.7.4 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.7.5 ViThera Pharmaceuticals Key News & Latest Developments
7.8 MicroBiome Therapeutics
7.8.1 MicroBiome Therapeutics Company Summary
7.8.2 MicroBiome Therapeutics Business Overview
7.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.8.4 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.8.5 MicroBiome Therapeutics Key News & Latest Developments
7.9 Osel
7.9.1 Osel Company Summary
7.9.2 Osel Business Overview
7.9.3 Osel Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.9.4 Osel Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Osel Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck Human Microbiome Based Drugs and Diagnostics Major Product Offerings
7.10.4 Merck Human Microbiome Based Drugs and Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
